Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health.

Beyer K, Zaura E, Brandt BW, Buijs MJ, Brun JG, Crielaard W, Bolstad AI.

PLoS One. 2018 Sep 19;13(9):e0202278. doi: 10.1371/journal.pone.0202278. eCollection 2018.

2.

Marine ω-3, vitamin D levels, disease outcome and periodontal status in rheumatoid arthritis outpatients.

Beyer K, Lie SA, Kjellevold M, Dahl L, Brun JG, Bolstad AI.

Nutrition. 2018 Nov;55-56:116-124. doi: 10.1016/j.nut.2018.03.054. Epub 2018 Apr 4.

3.

T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome.

Brokstad KA, Fredriksen M, Zhou F, Bergum B, Brun JG, Cox RJ, Skarstein K.

Scand J Immunol. 2018 Jun 8:e12679. doi: 10.1111/sji.12679. [Epub ahead of print]

PMID:
29882349
4.

Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.

Davies R, Hammenfors D, Bergum B, Vogelsang P, Gavasso S, Brun JG, Jonsson R, Appel S.

Eur J Immunol. 2018 Jul;48(7):1217-1227. doi: 10.1002/eji.201747213. Epub 2018 Apr 26.

PMID:
29604049
5.

Patients with Primary Sjögren's Syndrome Have Alterations in Absolute Quantities of Specific Peripheral Leucocyte Populations.

Davies R, Hammenfors D, Bergum B, Jakobsen K, Solheim M, Vogelsang P, Brun JG, Bryceson Y, Jonsson R, Appel S.

Scand J Immunol. 2017 Dec;86(6):491-502. doi: 10.1111/sji.12622.

6.

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, Hammenfors D, Jonsson MV, Skarstein K, Brun JG; DISSECT consortium, Rönnblom L, Forsblad-d'Elia H, Magnusson Bucher S, Baecklund E, Theander E, Omdal R, Jonsson R, Nordmark G, Wahren-Herlenius M.

Biol Sex Differ. 2017 Aug 8;8(1):25. doi: 10.1186/s13293-017-0146-6.

7.

Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.

Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, Wang S, He B, Grundahl KM, Glenn SB, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, Harboe E, Guthridge JM, Kaufman KM, Kvarnström M, Cunninghame Graham DS, Patel K, Adler AJ, Farris AD, Brennan MT, Chodosh J, Gopalakrishnan R, Weisman MH, Venuturupalli S, Wallace DJ, Hefner KS, Houston GD, Huang AJW, Hughes PJ, Lewis DM, Radfar L, Vista ES, Edgar CE, Rohrer MD, Stone DU, Vyse TJ, Harley JB, Gaffney PM, James JA, Turner S, Alevizos I, Anaya JM, Rhodus NL, Segal BM, Montgomery CG, Scofield RH, Kovats S, Mariette X, Rönnblom L, Witte T, Rischmueller M, Wahren-Herlenius M, Omdal R, Jonsson R, Ng WF; for UK Primary Sjögren's Syndrome Registry, Nordmark G, Lessard CJ, Sivils KL.

PLoS Genet. 2017 Jun 22;13(6):e1006820. doi: 10.1371/journal.pgen.1006820. eCollection 2017 Jun.

8.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, Kvarnstrom M, Sene D, Gerli R, Praprotnik S, Isenberg D, Solans R, Rischmueller M, Kwok SK, Nordmark G, Suzuki Y, Giacomelli R, Devauchelle-Pensec V, Bombardieri M, Hofauer B, Bootsma H, Brun JG, Fraile G, Carsons SE, Gheita TA, Morel J, Vollenveider C, Atzeni F, Retamozo S, Horvath IF, Sivils K, Mandl T, Sandhya P, De Vita S, Sanchez-Guerrero J, van der Heijden E, Trevisani VFM, Wahren-Herlenius M, Mariette X, Ramos-Casals M; EULAR-SS Task Force Big Data Consortium.

Ann Rheum Dis. 2017 Jun;76(6):1042-1050. doi: 10.1136/annrheumdis-2016-209952. Epub 2016 Nov 29.

PMID:
27899373
9.

Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome.

Balarini GM, Zandonade E, Tanure L, Ferreira GA, Sardenberg WM, Serrano ÉV, Dias CC, Navarro TP, Nordal HH, Mydel PM, Brun JG, Brokstad KA, Gerdts E, Jonsson R, Valim V.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1006-1012. Epub 2016 Sep 8.

PMID:
27749218
10.

Sjögren's syndrome patients with ectopic germinal centers present with a distinct salivary proteome.

Delaleu N, Mydel P, Brun JG, Jonsson MV, Alimonti A, Jonsson R.

Rheumatology (Oxford). 2016 Jun;55(6):1127-37. doi: 10.1093/rheumatology/kew013. Epub 2016 Feb 26.

PMID:
26921905
11.

Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps.

Valim V, Gerdts E, Jonsson R, Ferreira GA, Brokstad KA, Brun JG, Midtbø H, Mydel PM.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):133-42. Epub 2016 Jan 20. Review.

PMID:
26812164
12.

Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment.

Selaas O, Nordal HH, Halse AK, Brun JG, Jonsson R, Brokstad KA.

Int J Rheumatol. 2015;2015:276815. doi: 10.1155/2015/276815. Epub 2015 Dec 16.

13.

Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.

Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK.

Scand J Rheumatol. 2016 Jul;45(4):274-81. doi: 10.3109/03009742.2015.1107128. Epub 2016 Jan 15.

PMID:
26767827
14.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

15.

TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.

Karlsen M, Jonsson R, Brun JG, Appel S, Hansen T.

Scand J Immunol. 2015 Dec;82(6):523-31. doi: 10.1111/sji.12368.

16.

Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.

Karlsen M, Hansen T, Nordal HH, Brun JG, Jonsson R, Appel S.

PLoS One. 2015 Mar 19;10(3):e0120383. doi: 10.1371/journal.pone.0120383. eCollection 2015.

17.

High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.

Delaleu N, Mydel P, Kwee I, Brun JG, Jonsson MV, Jonsson R.

Arthritis Rheumatol. 2015 Apr;67(4):1084-95. doi: 10.1002/art.39015.

18.

Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.

Hammenfors DS, Brun JG, Jonsson R, Jonsson MV.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):56-62. Epub 2014 Dec 22.

19.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5.

PMID:
25480887
20.

The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab.

Nordal HH, Brun JG, Halse AK, Jonsson R, Fagerhol MK, Hammer HB.

BMC Musculoskelet Disord. 2014 Oct 4;15:335. doi: 10.1186/1471-2474-15-335.

Supplemental Content

Loading ...
Support Center